The effect of missing data in causal inference problems is widely recognized. In malaria drug efficacy studies, it is often difficult to distinguish between new and old infections after treatment, resulting in indeterminate outcomes. Methods that adjust for possible bias from missing data include a variety of imputation procedures (extreme case analysis, hot-deck, single and multiple imputation), weighting methods, and likelihood based methods (data augmentation, EM procedures and their extensions). In this article, we focus our discussion on multiple imputation and two weighting procedures (the inverse probability weighted and the doubly robust (DR) extension), comparing the methods' applicability to the efficient estimation of malaria treatment effects. Simulation studies indicate that DR estimators are generally preferable because they offer protection to misspecification of either the outcome model or the missingness model. We apply the methods to analyze malaria efficacy studies from Uganda.
Introduction
Randomized controlled trials (RCTs) are pivotal to public health and medical decisions because they have the potential to produce unbiased estimates of causal effects, allowing appropriate evaluation of competing treatments or interventions. Missing data are a particular problem when using a RCT to estimate causal effects because of potential bias introduced from broken randomization. A recent review of published randomized controlled trials in major medical journals established that missing outcome data are a common problem and are often inadequately handled in statistical analyses. 1 Despite extensive studies of causal inference in the presence of missing data, statistical practice often excludes observations with any missing outcomes (complete case (CC) analysis), simplifying the analysis at the expense of increased bias and reduced efficiency due to reduced sample sizes. CC analyses ignore the possibility of existence of systematic differences between complete and incomplete data cases, and the resulting inference may not be generalizable to the population, especially when the degree of incompleteness is high. Another approach to analysis of missing data is to impute missing values with worst-possible (or best-possible) values (also known as extreme case (EC) analysis). This approach has merit only as a form of sensitivity analysis. 2 Other imputation methods such as multiple imputation (MI) 3 are attractive under certain assumptions on the missing data mechanism. Rubin 4 defined the following missingness patterns based on how missing variable indicators are related to the underlying values of the variables in the data set. Let δ be the missingness indicator where δ = 1 if outcome Y is observed and δ = 0 otherwise. The missing data mechanism can be described by the conditional distribution of the missingness indictor δ given the complete data (W, A, Y), where A is the treatment variable and W are measured covariates. Let π(W, A, Y) = P(δ = 1|W, A, Y). Following Rotnitzky et al., 5 the distribution of the missingness variable δ can be expressed in terms of the logistic model
where η(A, W) is an unknown function of A and W, and q(Y) is a specified function of Y.
Data are said to be 'missing completely at random' (MCAR) if the probability of an observation being missing is independent of all measured variables and outcomes that is π (W, A, Y) = c for some constant c ∈ (0, 1). When the probability of an observation being missing is conditionally independent of unobserved data, given the values of the observed variables, then data are said to be 'missing at random' (MAR). The probability of missing outcome Y is independent of the unobserved Y value given treatment A and covariate W that is, π(W, A, Y) = π(W, A). Finally, data are 'missing not at random' (MNAR) when missingness depends on unobserved values Y after conditioning on the observed data.
In malaria drug efficacy studies the objective is to compare the efficacy of different antimalarial treatments in curing infection. The success or failure of antimalarial drugs in eliminating malaria parasites in infected individuals can be clinically undetermined. In highly endemic areas where recurrent disease following malaria therapy is common, 6 it is clinically impossible to distinguish recrudescence (true treatment failure) from new infections and so molecular genotyping techniques have been used to distinguish between re-infection and recrudescence. 7 Molecular genotyping compares genotype patterns based on highly polymorphic genes in pre-and post-treatment samples in patients with recurrent malaria. Post-treatment samples containing only parasite strains present in pre-treatment samples are classified as recrudescence of resistant parasites. Post-treatment samples containing only new parasite strains are generally classified as newly acquired infections. However, a complex situation arises when post-treatment samples contain new strains as well as some strains from pre-treatment samples (a mixed genotype result). Classifying mixed genotyping results as either due to recrudescence or new infections likely over-or under-estimates the true risk of treatment failure, respectively. In circumstances like these the mixed genotype is regarded as a missing outcome, complicating estimation of treatment effects. Moreover, the pattern of missingness observed in malaria data is not easy to determine and analyses have to be made under assumptions such as MAR and MCAR that cannot be easily verified. Identifying statistical methods robust to the underlying missingness mechanism is important in malaria drug efficacy studies.
In this article, we explore methods suitable for the estimation of treatment effects in malaria studies in the presence of indeterminate outcomes (i.e., mixed genotypes). We start by reviewing the causal inference framework given complete observed data. In section 2, we present estimation methods for causal parameters of interest in the presence of missing values. First, we briefly review the MI procedure, a technique for analysis of missing data due to Rubin et al. 3 Next, we review a weighted regression method, developed to remove potential bias introduced through unequal distribution of auxiliary factors. We also present G-computation approach to the missing data problem. Finally, we present the double robust extension to the inverse probability of censoring weighted estimator. In section 3, we compare estimates from the four procedures in addition to the EC analyses, in which all missing data are given either the worst case outcome (i.e, mixed genotype = failure), or the best case outcome (mixed genotype = non-failure) and the CC analyses using simulated data. We present results comparing the different approaches to a full data (FD) analysis in which missingness is absent. An application of the methods to malaria-treatment efficacy data is presented in section 4. The R code used to run the simulations is included in the appendix.
Estimation of causal effects
The statistical framework for causal inference that has been widely used is one based on potential outcomes, originally introduced by Neyman (1923) for randomized experiments, and generalized and extended by Rubin to non-randomized studies. Under this framework, a study unit has the potential to be given any of the experimental treatments, and associated with each treatment is a potential outcome, defined as the outcome that would be observed when that treatment is applied to that unit. 8 Consider a study with a binary treatment A, where A = 1 if treatment is given and A = 0 if it is not. The variables Y a=1 and Y a=0 denote a subject's outcome we would observe if treated and if not treated, respectively. The causal effect of treatment is obtained by comparing the two treatment marginal means E(Y a ) or functions of the treatment marginal means. For example, if Y is binary, then the causal effect of treatment is defined by either the risk difference, RD = P(Y a=1 = 1) − P(Y a=0 = 1), the risk ratio, RR = P(Y a=1 = 1) P(Y a=0 = 1) or the odds ratio, OR = P(Y a=1 = 1)×(1−P(Y a=0 = 1)) P(Y a=0 = 1)×(1−P(Y a=1 = 1)) . For continuous or categorical treatment A, the causal effect can be expressed in terms of parameters of a generalized linear model. In the case of a binary outcome where we choose the odds ratio as the measure of causal effect, we have the logistic model logit P(Y a = 1) = β 0 + β 1 a. The causal odds ratio equals exp β 1 . If treatment is unconfounded, the causal odds ratio equals the odds ratio estimated from the regression of Y on A. However, when some outcomes are missing, the usual regression method may produce biased parameter estimates.
MI Procedure
First introduced by Rubin, 4 MI is a simulation-based approach, where each missing value Y mis is replaced with a vector of D > 1 plausible values creating D datasets. Complete data methods such as those discussed above are applied to each dataset, and the parameter of interest is estimated by combining estimates from the imputed datasets. The reader is referred to detailed MI discussions. 4 In the malaria setting, we have a simple univariate missing pattern, where only the outcome Y is missing. We consider a parametric regression approach to MI. Our imputation model involves fitting a logistic regression logit P(Y = 1|A, W) = α 0 + α 1 A + α 2 W using the complete data to get parameter estimates (α 0 ,α 1 ,α 2 ) with associated covariance matrix V, where V is the usual X X. Assuming the parameters α come from a multivariate normal distribution with mean (α 0 ,α 1 ,α 2 ) and covariance V, we randomly sample from this distribution to get parameters (α * 0 , α * 1 , α * 2 ). Each missing value y i is replaced by either sampling from a binomial distribution with probabilities obtained from taking the inverse logit of
A simple decision rule such as replacing the missing value by 1 if estimated probabilities are greater than 0.5 and 0 otherwise can be used. Multiple imputed datasets are generated by the repeated sampling of parameters from the same multivariate normal distribution. For each complete dataset, the causal effect β
a of treatment is estimated from the usual logistic regression of Y on A. After sufficient repeated impute-estimation steps, we estimate the causal effect by averaging the D marginal treatment effects from each data set β (d) a : d = 1, . . . , D. The variance estimate of β MI a comes from combining the between-imputation variance and the within-imputation variance. 9
General inverse probability weighted estimators
Weighting, as a bias reduction tool, has roots from survey sampling. In missing data problems, applying weights to CCs eliminates bias due to differential response related to variables associated with missingness, resulting in a balanced pseudo-population.
For the malaria example, we assume the mean of the distribution of the potential outcome for treatment a, Y a , has the form g(a, β), where g is some regression function (e.g., logistic regression) indexed by an unknown p-dimensional parameter vector β. In the absence of missing data, the parameter vector β is usually estimated from solving generalized estimating equations (GEE).
In the presence of missing data, Robins and colleagues proposed weighted GEE as a solution for parameter β, where the weights, w i , are the inverse of the estimated probability of being a CC. 10−13 The probability of being complete is estimated from the regression of the missingness indicator δ on the observed variables. The inverse weighting approach is semi-parametric, requiring only the form of the regression equation (e.g., linear or log linear) without specifying the distribution of the response variable. For consistent parameter estimates, the correct missingness distribution is needed.
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The implementation of the inverse probability weighted (IPW) estimator proceeds by first estimating the probability of observing a CC, π(A, W), and using the inverse estimated probabilities of observing an outcome, π −1 n , as weights in a weighted regression of Y on A. Since missingness is a binary variable, the probability of observing an outcome is estimated using logistic regression. One gains efficiency asymptotically by estimating π(A, W) more nonparameterically, for instance using modeling techniques such as general additive models. 14 Even when the data are MCAR, we model the missingness indicator δ as a function of covariates W to gain efficiency. In practice, inverse probability weighted estimators are obtained from regular regression software that accepts weights. To derive proper inference for this estimator, we recommend using bootstrapping, where weights are recalculated for each bootstrap sample. This results in asymptotically valid standard error estimates ofβ IPW and works well in practice.
G-computation
Assuming data are MAR, Little and Rubin 3 (page 119) demonstrate that the likelihood of the observed data can be factored into a part that depends only on the distribution of the complete data, the missingness mechanism, and the distribution of the covariates
This representation requires first fitting a regression model for E(Y|δ = 1, A = a, W, γ ), or simply a regression of Y on A and W only among those with complete data (δ = 1). The marginal treatment mean µ a is estimated from the mean of the predicted values Xγ , where X is a design matrix from an n unit vector, A = a and W, (for all observations, even those with δ = 0) andγ is the maximum likelihood estimate from the regression of Y on A, W only among those subjects with δ = 1. If the model for Y is misspecified, the estimator for µ a , which we call the G-computation estimator,μ a , is inconsistent. Thus the G-computation method uses all the observations in the data set. The treatment effect β a is obtained from a function of µ a .
IPW doubly robust (IPW-DR) estimator
The IPW estimator does not make use of all available data since subjects with missing outcomes do not contribute. Moreover, the consistency of the IPW estimator depends on the correct specification of the missingness mechanism, π(W, A, Y), otherwise the parameter estimates can be inconsistent. On the other hand, the G-computation estimator uses all available data by averaging predictions over all observations and is consistent if the model for Y is correctly specified. However, if the model for Y is incorrect, G-computation gives an inconsistent estimate of the marginal mean µ a . The so-called double robust extension to the IPW estimator consistently estimates β whenever at least one of the two models (either for E(Y | A, W) or π(A, W)) is consistent. 10, 15 As before, the variance ofβ is best estimated using bootstrap procedures for the same reasons indicated for the IPW estimator.
The MI procedure contrasts with the G-computation procedure since they both rely on the correct specification of the model for Y. One can think of the MI procedure as part G-computation (over the missing data) and part simple averages of the Y's, but only over the data where A = a. If one assumes that the model for Y is consistent, then G-computation estimate must be more efficient, even after an infinite number of imputations. However, if the model for Y is misspecified the MI approach might be less biased if the proportion of missing data is small.
Simulation studies
In this section, we carry out simulation studies to compare treatment effect estimators from
• conventional regression analysis on CCs only.
• conventional regression on all cases where missing values have been imputed using MI procedures. • IPW estimation discussed in section (2) in which the naive estimating equation is weighted according to estimated probability of missingness given the observed data. • DR estimation obtained by solving augmented IPW estimating equations.
• conventional regression analysis assuming all missing cases are non-failures.
• conventional regression analysis assuming all missing cases are failures.
The simulations are motivated by malaria drug efficacy studies in which we would like to estimate and compare treatment specific risks of failure when some outcomes are indeterminate. We study the bias and efficiency of the estimators under MAR assumptions.
For each of the n observations, we generate a normally distributed covariate W ∼ N(0, 1), a Bernoulli treatment variable A with probability Pr(A = 1|W) = exp(w) 1+exp(w) , and a binary outcome variable Y according to the following logit model:
for selected values of β = (β 0 , β 1 , β 2 ). Assuming outcomes are MAR, we generate a missingness indicator δ for each observation from the Bernoulli distribution with parameter given by the logit function:
We consider two missingness scenarios. Setting (α 0 , α 1 , α 2 ) = (2, −1, 1) 24% of the cases have missing outcomes: 27% missingness in the treatment arm (A = 1) and 22% missingness in the control arm (A = 0). Setting (α 0 , α 1 , α 2 ) = (1, 2, 1) results in differential missingness where 10% of cases in the treatment arm and 25% of cases in the control arm are missing amounting to 18% overall missingness. With respect to the outcome data generating model, we set the parameter values to (β 0 , β 1 , β 2 ) = (0.5, −2, 2).
We also examine the robustness of the estimators to misspecification of the data imputation model (i.e., the conditional distribution of Y given treatment and covariates) and misspecification of the missingness mechanism by comparing the associated bias. In this regard, we misspecify the data model by modeling it as function of covariates alone. Similarly, we misspecify the missingness model in estimating weights by modeling the probability of being observed as a function of either treatment or covariates alone. For each set of simulations, we generated 2000 data sets of sample size n = 200. The six estimators were compared to the true parameter by studying the bias, normalized variance and relative mean square error comparing the CC to each estimator. Simulation results are summarized in tables 1-3 and figure 1 from which we observe the following: 1) Under the correct data imputation model and correct missingness mechanism, MI, and inverse weighted methods (IPW, DR) perform comparably and are all better than the CC estimator. Although the MI estimator is more biased than both inverse weighting estimators, it gains in precision. Under correct data and missingness model the MI estimator is preferable because it has the least mean square error irrespective of the missingness pattern (Tables 1 and 2) . 2) Augmentation of IPW weighted estimator indeed improves the mean square error of the IPW. The double robust estimator consistently shows smaller variance than the IPW estimator. 3) Figure 1 shows the effect of increasing missingness levels on estimator bias. MI and inverse weighted estimators have lower bias than the CC estimator over varying levels of missingness. In all estimators, bias increases with increasing missingness. The increased bias in MI, inverse weighted and DR estimators likely comes from the increased uncertainty arising from using fewer observations to estimate the data model and the missingness weights. 4) When we use an incorrect data generating model, MI estimation has higher bias compared to inverse weighted and DR estimation. In this case, the MI estimator performs worse than the CC analysis estimator (RMSE = 0.893) ( Table 3 ). The double robust estimator is not affected by the misspecified data model, performing as good as the IPW estimator and better than the CC estimator. 5) An incorrect missingness model results in biased IPW and DR estimates even when the data generating model is correctly specified. However, DR estimation results in slightly lower bias than the IPW estimator (Table 3 ). Information recovered from the covariates of cases with missing outcomes by the augmentation in DR estimation reduce the bias observed in IPW estimation.
We applied the methods discussed above to malaria data from randomized studies in Uganda. The studies were designed to compare the effectiveness of three antimalarial drug regimens. Malaria infected patients from regions of different transmission intensities were randomized to three treatment arms: chloroquine plus sulfadoxinepyrimethamine (CQSP), ammodiaquine plus sulfadoxine-pyrimethamine (AQSP) and ammodiaquine plus artesunate (AQAS). CQSP is the standard treatment and has been widely used while AQSP and AQAS are new treatments under clinical investigation. Participants were evaluated for malaria infection at baseline (i.e., before treatment), 3, 7, 14, 21 and 28 days after start of treatment by looking at the genotype of the infecting strains to see if treatment had been successful. Baseline covariates include age, gender, parasite density, temperature, transmission intensity and genotype. In this analysis, the outcome of interest is infection status 28 days after start of treatment.We restrict the analysis to two treatment arms (CQAS and AQSP). The outcome is classified into three groups: treatment failure, success or indeterminate. Overall, 25% of 2048 patients had indeterminate outcomes. 33% of the 1018 patients who received the standard of care treatment (CQSP) and 17% of 1030 who received AQSP had indeterminate outcomes respectively. The odds of an indeterminate outcome given the standard of care was 2.4 times the odds of an indeterminate outcome given the experimental treatment, an indication of strong differential missingness. Among patients with observed outcomes, 50% of patients receiving standard of care treatment (CQSP) failed compared to a 18% failure rate among patients receiving the experimental treatment (AQSP), a 78% reduction in treatment failure due to the new treatment AQSP.
We estimated the probability of observing a definite outcome using a logistic regression model with treatment, age, gender, baseline temperature, log baseline parasite density, baseline number of alleles (malaria strains), transmission intensity and time on treatment as predictors. Weights were calculated by taking the inverse of the estimated probability of observing an definite outcome. We estimated the marginal treatment-treatment specific failure rates and associated odds ratios as described above. We estimated 95% confidence intervals using 1000 bootstrap samples. We also investigated treatment effects across different transmission intensities. Table 4 shows the estimated coefficients, corresponding treatment-specific failure rates and associated 95% confidence intervals, and the estimated odds ratio. The estimated treatment coefficients for the experimental drug (AQSP) agree very well for all estimators except the two EC estimators. The simulation studies indicated that under treatment differential missingness, the IPW and the MI estimators were the least biased, and indeed the estimated treatment specific failure rates for the two estimators agree very well (CQSP = 53.1% and AQSP = 19.3% or 19.5%). Ignoring indeterminate outcomes by analyzing only CCs underestimates (CQSP = 49.9% and AQSP = 17.8%) the true failure rates by between 2 and 3 percentage points (assuming MI or IPW estimates are closer to the truth). We conclude from the analyses that the experimental treatment (AQSP) significantly improves malaria infection rates compared to the standard regimen (CQSP). Using any of the four non-extreme methods would result in almost equivalent treatment effects (odds ratios: CC = 0.218, MI = 0.214, IPW = 0.212, DR = 0.210) but the EC methods would result in substantially different treatment effects (EC-NF = 0.346, EC-F = 0.234). Table 5 shows the estimated risk of failure for each estimator by transmission intensity. MI, IPW and DR estimators have similar estimated failure risks at each transmission intensity level for each treatment group. Generally, the risk of treatment failure appears to decrease with increasing transmission intensity, although differences in failure risk are minor between mid-level transmission intensities (2) (3) (4) (5) .
Results
Transmission intensity appear to substantially confound treatment effect. Among patients treated with CQSP, missingness rates are higher compared to those treated with AQSP, and the MI, IPW and DR estimates are much closer to the EC estimator in which all mixed genotypes are treated as failures in lower transmission sites whereas the MI, IPW and DR estimates are closer to the EC estimate in which all mixed genotypes are treated as non-failures in high-transmission sites. Among AQSP treated patients, in almost all sites except the site with the lowest transmission intensity, the MI, IPW and DR estimators are closer to estimates where mixed genotypes are assumed to be nonfailures. These results seem to suggest that as you move from a less effective drug (CQSP) to a more effective drug (AQSP), mixed genotypes are less likely to be recrudesences (old infections), but new infections. At the same time, as you move from low-transmission sites to high-transmission sites, mixed genotypes are more likely to be new infections than old infections. Thus the size and direction of bias in the EC estimators depends on drug as well as transmission intensity.
CC, MI and inverse weighting approaches to analysis of the Uganda studies arrive at the same conclusion. AQSP reduces the risk of malaria infection when treated with CQSP by about 79%. These results confirm the reduced efficacy of chloroquine (CQ) containing regiments due to wide spread chloroquine resistance.
Discussion
We compared the performance of six statistical approaches to the analysis of missing outcome data in randomized studies. The simulation results demonstrate that under correct data and missingness models, MI and IPW methods perform better than CC and EC approaches. However, bias in all estimators increases with increasing levels of missingness. Our simulation results provide guidance to appropriate statistical methods for the analysis of randomized controlled studies in which the outcome is sometimes missing.
MI requires the correct data generating model while the inverse weighting requires a correct missingness model. The DR estimator requires either correct data model or missingness model, however, the missingness model appears to have more influence on the estimator than the data model. Under correct model specifications, MI, IPW and DR perform comparably better than CC under varying levels of missingness. A good imputation model can be obtained by fitting a very large model, maybe using general additive models or some model selection techniques. Similarly, a good missingness model is obtained from large models using additive models or some predictive modeling techniques.
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